Baxter

Starbreeze AB (publ) interim report January-September 2023

Retrieved on: 
Giovedì, Novembre 16, 2023
Epic Games Store, Weapon, Game, DNA, SEK, Epic, Running, Steam, Torus Games, Fortnite, Baxter, Digital Bros, PlayStation 5, AGM, Studio, Xbox, Environment, DAU, PlayStation, Poverty industry, Video game

STOCKHOLM, Nov. 16, 2023 /PRNewswire/ --

Key Points: 
  • August 10, Starbreeze announced that it will publish Roboquest by RyseUp Studios, version 1.0 to be released on November 7, 2023
    September 22, worldwide launch of PAYDAY 3, Starbreeze has recouped initial investment as of September 30th.
  • November 3, Starbreeze announced that it will publish GodsTV by Melbot Studios for release in 2026.
  • November 10, Starbreeze' Chairman Torgny Hellström announced that he declines re-election at the 2024 AGM.
  • Starbreeze' net sales amounted to close to half a billion SEK during the quarter, of which PAYDAY 3 accounted for SEK 441 million.

Spectral Medical Announces Third Quarter Results and Provides Corporate Update

Retrieved on: 
Giovedì, Novembre 9, 2023
BAX, NYSE, Clinical professor, Septic shock, Emory Healthcare, Mortality, FX, Sepsis, Grace note, Balancing, USD, Patient, TSX, Mayo Clinic, Pharmaceutical industry, Nursing, Fine chemical, Baxter, Spectral

TORONTO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the third quarter ended September 30, 2023 and provided a corporate update.

Key Points: 
  • TORONTO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the third quarter ended September 30, 2023 and provided a corporate update.
  • During the third quarter, the Company continued to experience momentum in Tigris Trial enrollment.
  • Dr. John Kellum, Chief Medical Officer of Spectral Medical, stated, “We continue to experience patient enrollment momentum supported by new sites we have onboarded during 2023.
  • The Company concluded the third quarter of 2023 with cash of $5,031,000 compared to $8,414,000 of cash on hand as of December 31, 2022.

Miami Entrepreneur Frances Rios Launches Anthology Book Showcasing Latina Business Leaders' Rise to Excellence; Reframing Perspectives presents 21 Puerto Rican authors

Retrieved on: 
Mercoledì, Novembre 8, 2023
Baxter, Santander Bank, ManpowerGroup, Walmart, Hope, The Next Level, Merck, Empowerment, Silver Legacy Resort & Casino, SAN, Woman, Ascena Retail Group, Entertainment, Management, Hotel, Humana, PepsiCo

SAN JUAN, Puerto Rico, Nov. 8, 2023 /PRNewswire-PRWeb/ --  A captivated audience of over 300 leaders was treated to a mosaic of tales capturing resilience, challenges, and triumphs, all shared by 21 distinguished Puerto Rican women business trailblazers. This momentous occasion celebrated the release of the anthology, "Reframing Perspectives: Latina Leaders Who Have Taken Their Story to The Next Level."

Key Points: 
  • This momentous occasion celebrated the release of the anthology, "Reframing Perspectives: Latina Leaders Who Have Taken Their Story to The Next Level."
  • This momentous occasion celebrated the release of the anthology, "Reframing Perspectives: Latina Leaders Who Have Taken Their Story to The Next Level."
  • Frances Rios , a Miami-based entrepreneur, international speaker, and author, is the driving force behind this anthology.
  • Rios passionately conveyed the uniqueness of the anthology, noting the absence of such a focus on Puerto Rican businesswomen.

Baxter Reports Third-Quarter 2023 Results

Retrieved on: 
Giovedì, Novembre 2, 2023
Biotechnology, Pharmaceutical, Optical, Medical Supplies, General Health, Health, Medical Devices, Health Technology, Baxter, Warburg Pincus, Tazobactam, BVLOS drone medical delivery trials in India, Piperacillin, Growth, EPS, Risk, BPS, Advent International, Medicine, Breakout Labs, EMR, Eye, Patient, Peritoneal dialysis, CDT, Pharmaceutical industry, Cassette tape, Fine chemical, Hemodialysis, Medication

Under the terms of the definitive agreement, Baxter received total proceeds of $4.25 billion, subject to adjustment for specified items.

Key Points: 
  • Under the terms of the definitive agreement, Baxter received total proceeds of $4.25 billion, subject to adjustment for specified items.
  • Baxter currently expects the Kidney Care spinoff to occur by July 2024 or earlier, subject to the satisfaction of customary conditions.
  • Baxter expects sales growth from continuing operations of 1% to 2% on a reported basis and approximately 1% on a constant currency basis.
  • A webcast of Baxter’s third-quarter 2023 conference call for investors can be accessed live from a link on the company’s website at www.baxter.com beginning at 7:30 a.m. CDT on Nov. 2, 2023.

Siemens Healthineers Selects Baxter Planning To Transform its Service Supply Chain

Retrieved on: 
Mercoledì, Novembre 1, 2023
Baxter, Center of excellence, Service, Siemens Healthineers, Automation, Senior, COE, Growth, Partnership, Assumption-based planning, Hospital, Civil Service Supply Association, Spare Parts, Burn, Total cost, Patient, 3D printing, Nursing, Warehouse, Medical imaging

AUSTIN, Texas, Nov. 1, 2023 /PRNewswire/ -- Baxter Planning, the leading provider of Service Parts Management technology, today announced that Siemens Healthineers, a leading medical technology company, has selected Baxter Planning as their long-term Service Supply Chain partner. Siemens Healthineers will be leveraging Baxter Planning's BaxterPredict, an end-to-end predictive platform to support the global Service Supply Chain at Siemens Healthineers Customer Services.

Key Points: 
  • AUSTIN, Texas, Nov. 1, 2023 /PRNewswire/ -- Baxter Planning, the leading provider of Service Parts Management technology, today announced that Siemens Healthineers, a leading medical technology company, has selected Baxter Planning as their long-term Service Supply Chain partner.
  • Siemens Healthineers will be leveraging Baxter Planning's BaxterPredict, an end-to-end predictive platform to support the global Service Supply Chain at Siemens Healthineers Customer Services.
  • After an extensive evaluation, Siemens Healthineers selected Baxter Planning based on their leading Service Parts Planning solution and domain expertise.
  • This new, predictive approach to inventory planning, demand forecasting, product-lifecycle planning, operations-workflow monitoring, reverse logistics, and customer-escalation management unlocks significant new value for Service Supply Chain organizations.

Oneview Healthcare and Baxter Announce Connected Care Collaboration During Meeting with Enterprise Ireland

Retrieved on: 
Martedì, Ottobre 17, 2023
Hardware, Telemedicine, Virtual Medicine, Data Management, Consumer Electronics, Technology, Other Policy Issues, Audio, Video, Practice Management, Apps, Applications, General Health, Hospitals, Public Policy, Government, Software, Nursing, Health, Baxter International, Partnership, Nursing care plan, Multimedia, Hospital, Midwestern United States, Health care, AUC, Employment, Caregiver, Baxter, Education, Enterprise, CXP, Growth, Oneview, Patient, Enterprise Ireland

Oneview Healthcare (Oneview), a leading provider of patient experience solutions, and Baxter International Inc. (Baxter), a global medtech leader, are pleased to announce the official launch of their strategic relationship in the United States.

Key Points: 
  • Oneview Healthcare (Oneview), a leading provider of patient experience solutions, and Baxter International Inc. (Baxter), a global medtech leader, are pleased to announce the official launch of their strategic relationship in the United States.
  • View the full release here: https://www.businesswire.com/news/home/20231017296352/en/
    Oneview Healthcare, Enterprise Ireland, and Baxter at the Baxter Headquarters.
  • Baxter will now offer Oneview’s Care Experience Platform (CXP) to their hospital customers across the United States.
  • During the meeting with the Irish government Minister for Enterprise, Trade, and Employment, Simon Coveney, representatives from both Oneview Healthcare and Baxter expressed their enthusiasm for the collaboration and outlined their shared vision for the future of healthcare.

BAXTER ALERT: Bragar Eagel & Squire, P.C. is Investigating Baxter International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Giovedì, Ottobre 12, 2023
Class Action Lawsuit, Professional Services, Legal, Jeanne Eagels, News, Baxter International, NYSE, Telephone, Face, P.C, Cryptocurrency, Baxter

Our investigation concerns whether the board of directors of Baxter have breached their fiduciary duties to the company.

Key Points: 
  • Our investigation concerns whether the board of directors of Baxter have breached their fiduciary duties to the company.
  • Following this news, Baxter shares fell $5.23 per share, or 11.5%, from $45.37 to close at $40.14 per share on February 9, 2023.
  • Over the course of the Class Period, Baxter’s stock price declined by nearly 50%, eliminating billions of dollars in market capitalization.
  • There is no cost or obligation to you.

Baxter Appoints Joel Grade Chief Financial Officer

Retrieved on: 
Martedì, Ottobre 3, 2023
Biotechnology, Health, Finance, Other Health, Accounting, Pharmaceutical, Surgery, Professional Services, Practice Management, Medical Devices, General Health, Hospitals, Health Technology, Medical Supplies, Specialization, University, Marketing, Baxter, Sysco, MBA, History, University of Wisconsin–Madison School of Education, Baxter International, Organization, In re Caremark International Inc. Derivative Litigation, Patient, Ernst, Ernst & Young, CFO, Growth, NYSE, Northwestern University Master of Product Design and Development Management, Kellogg School of Management, Management

Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed Joel Grade as executive vice president and chief financial officer (CFO), reporting to Baxter chairman, president and CEO, José (Joe) E. Almeida, effective Oct. 18, 2023.

Key Points: 
  • Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed Joel Grade as executive vice president and chief financial officer (CFO), reporting to Baxter chairman, president and CEO, José (Joe) E. Almeida, effective Oct. 18, 2023.
  • “Joel is a seasoned global financial executive with decades of deep operational and broad business experience as well as a proven record of results-driven impact,” said Mr. Almeida.
  • Mr. Grade brings deep experience from various financial, commercial and executive leadership roles.
  • “I’m very excited to join Baxter, an industry leader with a rich history, compelling future, patient-centric mission, and best-in-class talent,” said Mr. Grade.

Spectral Medical Provides Tigris Trial Update

Retrieved on: 
Martedì, Ottobre 3, 2023
Sepsis, Septic shock, Baxter, TSX, Mortality, Baxter International, Patient, PMX, Spectral, Pharmaceutical industry

TORONTO, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today provided an update on the progress of its Tigris trial including patient enrollment and new trial site additions to further accelerate patient enrollment.

Key Points: 
  • TORONTO, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today provided an update on the progress of its Tigris trial including patient enrollment and new trial site additions to further accelerate patient enrollment.
  • As of October 2, 2023, the Company had 74 patients enrolled in its Phase 3 Tigris clinical trial with crude mortality data continuing to exceed expectations.
  • To further accelerate patient enrollment, reach the interim milestone of 90 enrolled patients and subsequently complete the Tigris trial, Spectral is on track to add seven new vetted trial sites in the United States around the end of November 2023.
  • “We are taking decisive action to maintain and even increase momentum in patient enrollment with a view to enrolling our interim count of 90 patients, which is expected to play as a major catalyst for the Company,” said Chris Seto, Chief Executive Officer of Spectral Medical.

Global Blood Transfusion Set Market Expected to Rebound with 3.0% CAGR, Reaching $591 Million by 2030 - ResearchAndMarkets.com

Retrieved on: 
Venerdì, Settembre 29, 2023
Health, Other Health, Male, IV, Prevalence, ICU Medical, Pump, Baxter, Cancer, Luer, Domination, Research, BD (company), Blood transfusion, Chronic, BD, Medical device, Pharmaceutical industry, Alaris

In 2023, the global blood transfusion set market reported a total value of $480.1 million, experiencing a modest decline of 3.5% from the $464.1 million recorded in 2022.

Key Points: 
  • In 2023, the global blood transfusion set market reported a total value of $480.1 million, experiencing a modest decline of 3.5% from the $464.1 million recorded in 2022.
  • Currently, market leaders in the global blood transfusion set market include Becton Dickinson (BD), Baxter, and ICU Medical.
  • Rebound Expected: The global blood transfusion set market is projected to rebound with a CAGR of 3.0%, reaching a valuation of $591 million, following a 3.5% decline in 2023.
  • Dominant Players: Key players such as Becton Dickinson (BD), Baxter, and ICU Medical currently dominate the global blood transfusion set market.